Overview
Healthcare solutions firm's Q4 revenue rose 2% qtr/qtr to $35.2 mln
Adjusted EPS for Q4 was $0.16
Total Recurring Contract Value (TRCV) increased 8% yr/yr to $144.1 mln, growing sequentially for fifth consecutive quarter
Outlook
Company did not provide specific guidance for future quarters or full year
Result Drivers
TRCV GROWTH - Total Recurring Contract Value increased 8% year-over-year to $144.1 million, marking the fifth consecutive quarter of sequential growth
CASH FLOW INCREASE - Cash flow from operations rose 13% year-over-year to $7.2 million
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Revenue
$35.19 mln
Q4 Adjusted EPS
$0.16
Q4 Net Income
$1.80 mln
Press Release: ID:nBwb5SxPda
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)